GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (NAS:GEHC) » Definitions » Shares Outstanding (EOP)

GE HealthCare Technologies (GE HealthCare Technologies) Shares Outstanding (EOP) : 455 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is GE HealthCare Technologies Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. GE HealthCare Technologies's shares outstanding for the quarter that ended in Dec. 2023 was 455 Mil.

GE HealthCare Technologies's quarterly shares outstanding increased from Sep. 2023 (455 Mil) to Dec. 2023 (455 Mil). It means GE HealthCare Technologies issued new shares from Sep. 2023 to Dec. 2023 .

GE HealthCare Technologies's annual shares outstanding increased from Dec. 2022 (454 Mil) to Dec. 2023 (455 Mil). It means GE HealthCare Technologies issued new shares from Dec. 2022 to Dec. 2023 .


GE HealthCare Technologies Shares Outstanding (EOP) Historical Data

The historical data trend for GE HealthCare Technologies's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies Shares Outstanding (EOP) Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
454.71 454.71 454.71 454.00 455.34

GE HealthCare Technologies Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 454.00 454.62 454.81 455.22 455.34

Competitive Comparison of GE HealthCare Technologies's Shares Outstanding (EOP)

For the Health Information Services subindustry, GE HealthCare Technologies's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GE HealthCare Technologies's Shares Outstanding (EOP) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GE HealthCare Technologies's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's Shares Outstanding (EOP) falls into.



GE HealthCare Technologies Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


GE HealthCare Technologies  (NAS:GEHC) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


GE HealthCare Technologies Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


GE HealthCare Technologies (GE HealthCare Technologies) Business Description

Traded in Other Exchanges
Address
500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.
Executives
Kevin Michael O'neill officer: CEO, PDx 500 W. MONROE STREET, CHICAGO IL 60661
Roland Rott officer: CEO, Ultrasound 500 W. MONROE STREET, CHICAGO IL 60661
James Saccaro officer: Chief Financial Officer ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jan Makela officer: CEO, Imaging 500 W. MONROE STREET, CHICAGO IL 60661
Taha Kass-hout officer: Chief Technology Officer 500 W. MONROE STREET, CHICAGO IL 60661
Kenneth R. Stacherski officer: Ch. Supply Chain & Serv. Ofc. 500 W MONROE, CHICAGO IL 60661
Culp H Lawrence Jr director GENERAL ELECTRIC COMPANY, ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
William J Stromberg director 100 E. PRATT STREET, BALTIMORE MD 21202
Thomas J. Westrick officer: CEO, Patient Care Solutions 500 W. MONROE STREET, CHICAGO IL 60661
Yang Watkin Phoebe L. director C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Rodney F Hochman director 21919 30TH DR SE, BOTHELL WA 98021
Tomislav Mihaljevic director ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
Lloyd Jr Howell director 8283 GREENSBORO DRIVE, MCLEAN VA 22102
Anne T Madden director C/O HONEYWELL 300 S. TRYON STREET, CHARLOTTE NC 28202
Frank R Jimenez officer: GC & Corporate Secretary GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 606061